SEC Info - Asensus Surgical, Inc. - ‘8-K’ for 3/3/21

SEC Info℠

Home

Help

Please Sign In

Asensus Surgical, Inc. – ‘8-K’ for 3/3/21

On: Wednesday, 3/3/21, at 4:31pm ET · For: 3/3/21 · Accession #: 1437749-21-4854 · File #: 0-19437

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/03/21  Asensus Surgical, Inc.            8-K:8,9     3/03/21   12:171K                                   RDG Filings/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     24K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     13K 
 8: R1          Document And Entity Information                     HTML     48K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- transe20210303_8k_htm               XML     13K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- trxc-20210303_def                XML     38K 
 5: EX-101.LAB  XBRL Labels -- trxc-20210303_lab                     XML     49K 
 6: EX-101.PRE  XBRL Presentations -- trxc-20210303_pre              XML     37K 
 3: EX-101.SCH  XBRL Schema -- trxc-20210303                         XSD     14K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    20K 
12: ZIP         XBRL Zipped Folder -- 0001437749-21-004854-xbrl      Zip     13K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C:

i false i 0000876378 0000876378 2021-03-03 2021-03-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

_________________

FORM i 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

i March 3, 2021
Date of Report (date of earliest event reported)

_________________

i Asensus Surgical, Inc.

(Exact name of Registrant as specified in its charter)

_________________


i Delaware (State or other jurisdiction of incorporation or organization)		i 0-19437 (Commission File Number)		i 11-2962080 (I.R.S. Employer Identification Number)

i 635 Davis Drive, i Suite 300
i Morrisville, i North Carolina i 27560
(Address of principal executive offices)

i 919- i 765-8400
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

_________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol		Name of each exchange on which registered
i Common Stock $0.001 par value per share		i TRXC		i NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. C: ☐

Item 8.01 Other Events.

On March 3, 2021, Asensus Surgical, Inc., a Delaware corporation, issued a press release to announce that it had received an additional FDA clearance for the Senhance® Surgical System which allows for indication expansion in general surgery in the United States.

A copy of the press release is filed herewith as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)

Exhibit

Exhibit No. Description

99.1 Press release dated March 3, 2021

104 Cover Page Interactive Data File (formatted in inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ASENSUS SURGICAL, INC.

Date: March 3, 2021	/s/ *Shameze Rampertab*
	Shameze Rampertab Executive Vice President and Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on / For Period end:	3/3/21	None on these Dates
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/26/21  Asensus Surgical, Inc.            S-8         7/26/21    3:90K                                    RDG Filings/FA
 5/19/21  Asensus Surgical, Inc.            424B5                  1:315K                                   RDG Filings/FA
 5/19/21  Asensus Surgical, Inc.            S-3ASR      5/19/21    3:246K                                   RDG Filings/FA

↑Top

Filing Submission 0001437749-21-004854 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Asensus Surgical, Inc. – ‘8-K’ for 3/3/21

On: Wednesday, 3/3/21, at 4:31pm ET · For: 3/3/21 · Accession #: 1437749-21-4854 · File #: 0-19437

Current Report — Form 8-KFiling Table of Contents

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

3 Subsequent Filings that Reference this Filing

Current Report — Form 8-K
Filing Table of Contents